Award
NIH Reporter #5P30GM159561-02
COBRE Phase III
Recipient
University of Arkansas for Medical Sciences, Little Rock, AR
Award Amount
$1,147,500.00
Ceiling
$1,147,500.00
Awarded
June 18, 2026
Identifier
5P30GM159561-02
The COBRE Phase III award funds a research center at the University of Arkansas for Medical Sciences to study and reduce adverse effects of cancer therapy, supporting investigator development and enhancing research infrastructure.
Description
The COBRE Center for Studies of Host Response to Cancer Therapy aims to build a self-sustaining, multidisciplinary research center focused on understanding and mitigating adverse effects of cancer therapy. The center supports research from basic to clinical levels, with core facilities in bioanalytical and radiation/imaging sciences. The initiative seeks to enhance research infrastructure, foster investigator collaboration, and improve cancer survivorship outcomes.